Important: Big Changes to the MAT X-Waiver
Posted over 1 year ago by Deborah Tedesco
DEA X-Waiver Requirement Eliminated
The Drug Enforcement Agency (DEA) has announced that there is no longer a requirement for an X-Waiver (or DATA 2000 Waiver) to prescribe buprenorphine for the treatment of opioid use disorders (OUD), if the practitioner:
- Holds an active DEA license to prescribe controlled substances
- Is allowed to prescribe under their state nursing practice act and regulation
All practitioners who have a current DEA registration that includes Schedule III authority may now prescribe buprenorphine for OUD if permitted by applicable state law. Limits to the number of patients for which a practitioner can prescribe buprenorphine for OUD have also been removed.
The DEA and SAMHSA are developing further guidance, and new training requirements will be issued in June. APNA is monitoring this issue and will continue to keep you updated on any developments. Learn More
The DEA and SAMHSA are developing further guidance, and new training requirements will be issued in June. APNA is monitoring this issue and will continue to keep you updated on any developments. Learn More